KR880007553A - 항생물질 a 10255 복합체 및 요소, 및 이들의 제조방법 - Google Patents
항생물질 a 10255 복합체 및 요소, 및 이들의 제조방법 Download PDFInfo
- Publication number
- KR880007553A KR880007553A KR870014349A KR870014349A KR880007553A KR 880007553 A KR880007553 A KR 880007553A KR 870014349 A KR870014349 A KR 870014349A KR 870014349 A KR870014349 A KR 870014349A KR 880007553 A KR880007553 A KR 880007553A
- Authority
- KR
- South Korea
- Prior art keywords
- urea
- nrrl
- streptomyces
- complex
- measured
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000004202 carbamide Substances 0.000 title claims 19
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 title claims 17
- 238000000034 method Methods 0.000 title claims 6
- YRMCBQLZVBXOSJ-PCFSSPOYSA-N (e)-3-[(6r,6as)-4-hydroxy-6-methoxy-3-methyl-11-oxo-5,6,6a,7-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]prop-2-enamide Chemical compound CO[C@H]1NC2=C(O)C(C)=CC=C2C(=O)N2C=C(\C=C\C(N)=O)C[C@@H]12 YRMCBQLZVBXOSJ-PCFSSPOYSA-N 0.000 title 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims 30
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 27
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 12
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims 12
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 12
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims 12
- 239000000203 mixture Substances 0.000 claims 12
- 241000187747 Streptomyces Species 0.000 claims 11
- 230000009102 absorption Effects 0.000 claims 9
- 238000010521 absorption reaction Methods 0.000 claims 9
- 230000003115 biocidal effect Effects 0.000 claims 9
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims 8
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims 8
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 claims 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 8
- 238000000862 absorption spectrum Methods 0.000 claims 8
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 claims 8
- 150000003839 salts Chemical class 0.000 claims 8
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 claims 7
- 230000007935 neutral effect Effects 0.000 claims 6
- 229910052757 nitrogen Inorganic materials 0.000 claims 6
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 5
- 229910052799 carbon Inorganic materials 0.000 claims 5
- 238000000921 elemental analysis Methods 0.000 claims 5
- 239000000843 powder Substances 0.000 claims 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 4
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims 4
- 239000004473 Threonine Substances 0.000 claims 4
- 230000002378 acidificating effect Effects 0.000 claims 4
- 229910021529 ammonia Inorganic materials 0.000 claims 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 4
- 239000001963 growth medium Substances 0.000 claims 4
- 239000001257 hydrogen Substances 0.000 claims 4
- 229910052739 hydrogen Inorganic materials 0.000 claims 4
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 4
- 230000007062 hydrolysis Effects 0.000 claims 4
- 238000006460 hydrolysis reaction Methods 0.000 claims 4
- 229910052760 oxygen Inorganic materials 0.000 claims 4
- 239000001301 oxygen Substances 0.000 claims 4
- 229910052717 sulfur Inorganic materials 0.000 claims 4
- 239000011593 sulfur Substances 0.000 claims 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims 3
- 238000004949 mass spectrometry Methods 0.000 claims 3
- 230000000704 physical effect Effects 0.000 claims 3
- 241001465754 Metazoa Species 0.000 claims 2
- 239000003929 acidic solution Substances 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 2
- 239000003637 basic solution Substances 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 230000001747 exhibiting effect Effects 0.000 claims 2
- 238000000855 fermentation Methods 0.000 claims 2
- 230000004151 fermentation Effects 0.000 claims 2
- 238000007654 immersion Methods 0.000 claims 2
- 238000002329 infrared spectrum Methods 0.000 claims 2
- 244000144972 livestock Species 0.000 claims 2
- 238000002211 ultraviolet spectrum Methods 0.000 claims 2
- 150000003672 ureas Chemical class 0.000 claims 2
- 241000936695 Streptomyces gardneri Species 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 229940088710 antibiotic agent Drugs 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- 150000001720 carbohydrates Chemical class 0.000 claims 1
- -1 deuterated dimethyl siloxane Chemical class 0.000 claims 1
- 230000009977 dual effect Effects 0.000 claims 1
- 230000002708 enhancing effect Effects 0.000 claims 1
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 1
- 230000000813 microbial effect Effects 0.000 claims 1
- 239000011707 mineral Substances 0.000 claims 1
- 239000008188 pellet Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 claims 1
- 230000035939 shock Effects 0.000 claims 1
- 238000001228 spectrum Methods 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/465—Streptomyces
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Mycology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94189486A | 1986-12-15 | 1986-12-15 | |
| US94147386A | 1986-12-15 | 1986-12-15 | |
| US941894 | 1997-09-30 | ||
| US941473 | 1997-09-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR880007553A true KR880007553A (ko) | 1988-08-27 |
Family
ID=27130157
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR870014349A Ceased KR880007553A (ko) | 1986-12-15 | 1987-12-15 | 항생물질 a 10255 복합체 및 요소, 및 이들의 제조방법 |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0274873B1 (enExample) |
| JP (1) | JPS63258585A (enExample) |
| KR (1) | KR880007553A (enExample) |
| CN (1) | CN1023758C (enExample) |
| AU (1) | AU604806B2 (enExample) |
| DE (1) | DE3781878T2 (enExample) |
| DK (1) | DK654987A (enExample) |
| ES (1) | ES2052584T3 (enExample) |
| GR (1) | GR3006408T3 (enExample) |
| HU (1) | HU199559B (enExample) |
| IE (1) | IE60394B1 (enExample) |
| IL (1) | IL84819A (enExample) |
| MX (1) | MX170925B (enExample) |
| NZ (1) | NZ222895A (enExample) |
| PT (1) | PT86364B (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH25145A (en) * | 1986-12-15 | 1991-02-19 | Laverne Dwaine Boeck | Process for producing the a10255 complex and corresponding microorganism |
| US5229362A (en) * | 1986-12-15 | 1993-07-20 | Eli Lilly And Company | Antibiotic A10255 complex and factors, and process and production therefor |
| DE3851268T2 (de) * | 1987-06-19 | 1995-01-26 | Sandoz Ag | Zyklische Peptolide. |
| IT1234197B (it) * | 1988-06-14 | 1992-05-06 | Mini Ricerca Scient Tecnolog | Antibiotici ottenuti mediante coltivazione aerobica controllata dello streptomyces s.p. ncib 12629 |
| US6982251B2 (en) | 2000-12-20 | 2006-01-03 | Schering Corporation | Substituted 2-azetidinones useful as hypocholesterolemic agents |
| BRPI0206641B8 (pt) | 2001-01-26 | 2021-05-25 | Merck Sharp & Dohme | uso de um inibidor da absorção de esteróis |
| US7071181B2 (en) | 2001-01-26 | 2006-07-04 | Schering Corporation | Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors |
| SK288217B6 (sk) | 2001-01-26 | 2014-08-05 | Merck Sharp & Dohme Corp. | Zmes, terapeutická kombinácia, farmaceutický prostriedok a ich použitie |
| US7056906B2 (en) | 2001-09-21 | 2006-06-06 | Schering Corporation | Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women |
| DE60216300T2 (de) | 2001-09-21 | 2007-06-28 | Schering Corp. | Behandlung von xanthom mittels azetidinon-derivate als hemmer der sterol absorption |
| US7053080B2 (en) | 2001-09-21 | 2006-05-30 | Schering Corporation | Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors |
| AU2003291719A1 (en) | 2002-11-06 | 2004-06-03 | Schering Corporation | Cholesterol absorptions inhibitors for the treatment of autoimmune disorders |
| US20060243825A1 (en) | 2003-02-18 | 2006-11-02 | Keith Laidler | Dispenser pump |
| CN1756756A (zh) | 2003-03-07 | 2006-04-05 | 先灵公司 | 取代的2－吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途 |
| ES2311806T3 (es) | 2003-03-07 | 2009-02-16 | Schering Corporation | Compuesto de azetidinona sustituidos, fornulaciones y usos de los mismos para el tratamiento de hipercolesterolemia. |
| US7459442B2 (en) | 2003-03-07 | 2008-12-02 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
| CA2517573C (en) | 2003-03-07 | 2011-12-06 | Schering Corporation | Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia |
| KR20120093192A (ko) * | 2009-09-02 | 2012-08-22 | 피라말 라이프 사이언시스 리미티드 | 항생제 화합물 |
-
1987
- 1987-12-14 EP EP87310953A patent/EP0274873B1/en not_active Expired - Lifetime
- 1987-12-14 DK DK654987A patent/DK654987A/da not_active Application Discontinuation
- 1987-12-14 DE DE8787310953T patent/DE3781878T2/de not_active Expired - Fee Related
- 1987-12-14 IE IE339087A patent/IE60394B1/en not_active IP Right Cessation
- 1987-12-14 AU AU82493/87A patent/AU604806B2/en not_active Ceased
- 1987-12-14 IL IL84819A patent/IL84819A/xx not_active IP Right Cessation
- 1987-12-14 HU HU875637A patent/HU199559B/hu not_active IP Right Cessation
- 1987-12-14 NZ NZ222895A patent/NZ222895A/xx unknown
- 1987-12-14 ES ES87310953T patent/ES2052584T3/es not_active Expired - Lifetime
- 1987-12-15 JP JP62320067A patent/JPS63258585A/ja active Pending
- 1987-12-15 MX MX009771A patent/MX170925B/es unknown
- 1987-12-15 PT PT86364A patent/PT86364B/pt not_active IP Right Cessation
- 1987-12-15 CN CN87108341A patent/CN1023758C/zh not_active Expired - Fee Related
- 1987-12-15 KR KR870014349A patent/KR880007553A/ko not_active Ceased
-
1992
- 1992-12-02 GR GR920402772T patent/GR3006408T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK654987D0 (da) | 1987-12-14 |
| HU199559B (en) | 1990-02-28 |
| EP0274873A2 (en) | 1988-07-20 |
| JPS63258585A (ja) | 1988-10-26 |
| AU604806B2 (en) | 1991-01-03 |
| HUT49376A (en) | 1989-09-28 |
| PT86364A (en) | 1988-01-01 |
| IE873390L (en) | 1988-06-15 |
| CN87108341A (zh) | 1988-08-10 |
| EP0274873B1 (en) | 1992-09-23 |
| DE3781878D1 (de) | 1992-10-29 |
| EP0274873A3 (en) | 1989-08-09 |
| PT86364B (pt) | 1990-11-07 |
| IL84819A (en) | 1993-07-08 |
| ES2052584T3 (es) | 1994-07-16 |
| DK654987A (da) | 1988-09-23 |
| MX170925B (es) | 1993-09-22 |
| DE3781878T2 (de) | 1993-03-11 |
| CN1023758C (zh) | 1994-02-16 |
| IE60394B1 (en) | 1994-07-13 |
| NZ222895A (en) | 1992-08-26 |
| AU8249387A (en) | 1988-07-28 |
| GR3006408T3 (enExample) | 1993-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR880007553A (ko) | 항생물질 a 10255 복합체 및 요소, 및 이들의 제조방법 | |
| Yasumoto et al. | New tetrodotoxin analogs from the newt Cynops ensicauda | |
| JPH0574595B2 (enExample) | ||
| DE2754326C2 (de) | Antibiotikum AM 2282, seine Herstellung und Arzneimittel | |
| DE1795188A1 (de) | Cephalosporinderivate und Verfahren zu deren Herstellung | |
| US4416899A (en) | Antibiotic BMG162-aF2, a process for production thereof, and antitumor drug containing said new antibiotic as active ingredient | |
| KR840004168A (ko) | A41030 항생물질의 제조방법 | |
| KR890002418A (ko) | Ab-006 항생물질 및 그의 제조방법 | |
| DE3683860D1 (de) | Verbindung cl-1577-b4, ihre herstellung und verwendung. | |
| FI914477A0 (fi) | Mikrobiologiskt foerfarande foer framstaellning av hydroxylerade heterocykliska foereningar. | |
| ES417327A1 (es) | Un procedimiento para la produccion del antibiotico a-2315. | |
| KR840008817A (ko) | Bbm-1675, 새로운 항암 항생복합체 | |
| US4430429A (en) | Production of vitamin B12 -activity substances | |
| HARA et al. | DC 102, a new glycosidic pyrrolo (1, 4) benzodiazepine antibiotic produced by Streptomyces sp. | |
| ISSHIKI et al. | A new antibiotic indisocin and N-methylindisocin | |
| KR910014398A (ko) | 항생제 데옥시물룬도칸딘, 이의 제조방법 및 약제로서의 이의 용도 | |
| DE2645528C3 (de) | Antibiotisch wirksame Pyrrole [2,1c] -1,4benzdiazepine | |
| TYMIAK et al. | Oxazinomycin produced by a Pseudomonas species | |
| RU2001102052A (ru) | Мумбайстатин, способ его получения и его применение в качестве фармацевтического препарата | |
| US3769403A (en) | Ericamycin and production thereof | |
| GB1500847A (en) | Antibiotic a process for its preparation and its use as a medicament | |
| US4209509A (en) | Substance SF-1739 derivatives, process for preparing the same and antibacterial compositions containing the same | |
| JPH05271215A (ja) | 新規なポリエンマクロライド化合物及びそれを有効成分とする抗真菌剤 | |
| GB1494449A (en) | Ionomycin | |
| US3808331A (en) | Tetrahexin and process for preparing same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19871215 |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 19920825 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 19871215 Comment text: Patent Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 19960320 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 19960528 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 19960320 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |